Concepedia

Wensheng Yu

WY

45

Publications

1.8K

Citations

23

H-Index

1999

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

WuXi AppTec (China)

University of Iowa

United States Military Academy

Quantitative BioSciences

Wensheng Yu is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in drug discovery, medicine, and pharmacology.

ORCID

Top concepts

Publications per year

1999–2021

45

Publications

45

Improved Procedure for the Oxidative Cleavage of Olefins by OsO<sub>4</sub>−NaIO<sub>4</sub>

Wensheng Yu, Yan Mei, Ying Kang et al. · Organic Letters · 2004 · 427 citations

OSW-1: a Natural Compound With Potent Anticancer Activity and a Novel Mechanism of Action

Yan Zhou, Celia Garcı́a-Prieto, Dennis Carney et al. · JNCI Journal of the National Cancer Institute · 2005 · 102 citations

Total Synthesis of the Anticancer Natural Product OSW-1

Wensheng Yu, Zhendong Jin · Journal of the American Chemical Society · 2002 · 94 citations

A New Strategy for the Stereoselective Introduction of Steroid Side Chain via α-Alkoxy Vinyl Cuprates:  Total Synthesis of a Highly Potent Antitumor Natural Product OSW-1<sup>1</sup>

Wensheng Yu, Zhendong Jin · Journal of the American Chemical Society · 2001 · 82 citations

, , +14

Discovery of Potent and Orally Available Bicyclo[1.1.1]pentane-Derived Indoleamine-2,3-dioxygenase 1 (IDO1) Inhibitors

Qinglin Pu, Hongjun Zhang, Liangqin Guo et al. · ACS Medicinal Chemistry Letters · 2020 · 82 citations · Full text

Rows per page

1–5 of 45